FDA Inspection 785250 — AstraZeneca UK Ltd.

AstraZeneca UK Ltd. — FEI 3002850317

The FDA completed an inspection of AstraZeneca UK Ltd. on March 16, 2012 in Macclesfield. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 16, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Macclesfield (United Kingdom)

Citations

IDCFRDescription
145121 CFR 211.113(b)Procedures for sterile drug products
440221 CFR 211.192Written record of investigation incomplete